Literature DB >> 21196577

Quantitative mapping of reversible mitochondrial Complex I cysteine oxidation in a Parkinson disease mouse model.

Steven R Danielson1, Jason M Held, May Oo, Rebeccah Riley, Bradford W Gibson, Julie K Andersen.   

Abstract

Differential cysteine oxidation within mitochondrial Complex I has been quantified in an in vivo oxidative stress model of Parkinson disease. We developed a strategy that incorporates rapid and efficient immunoaffinity purification of Complex I followed by differential alkylation and quantitative detection using sensitive mass spectrometry techniques. This method allowed us to quantify the reversible cysteine oxidation status of 34 distinct cysteine residues out of a total 130 present in murine Complex I. Six Complex I cysteine residues were found to display an increase in oxidation relative to controls in brains from mice undergoing in vivo glutathione depletion. Three of these residues were found to reside within iron-sulfur clusters of Complex I, suggesting that their redox state may affect electron transport function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21196577      PMCID: PMC3045014          DOI: 10.1074/jbc.M110.190108

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Organization of iron-sulfur clusters in respiratory complex I.

Authors:  Philip Hinchliffe; Leonid A Sazanov
Journal:  Science       Date:  2005-07-29       Impact factor: 47.728

2.  Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson's disease.

Authors:  Michael Hsu; Bharath Srinivas; Jyothi Kumar; Rajagopalan Subramanian; Julie Andersen
Journal:  J Neurochem       Date:  2005-03       Impact factor: 5.372

3.  Drug quantitation on a benchtop liquid chromatography-tandem mass spectrometry system.

Authors:  P R Tiller; J Cunniff; A P Land; J Schwartz; I Jardine; M Wakefield; L Lopez; J F Newton; R D Burton; B M Folk; D L Buhrman; P Price; D Wu
Journal:  J Chromatogr A       Date:  1997-05-30       Impact factor: 4.759

4.  Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines.

Authors:  I A Trounce; Y L Kim; A S Jun; D C Wallace
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

5.  Mitochondrial complex I deficiency in Parkinson's disease.

Authors:  A H Schapira; J M Cooper; D Dexter; P Jenner; J B Clark; C D Marsden
Journal:  Lancet       Date:  1989-06-03       Impact factor: 79.321

6.  Rapid purification and mass spectrometric characterization of mitochondrial NADH dehydrogenase (Complex I) from rodent brain and a dopaminergic neuronal cell line.

Authors:  Birgit Schilling; Srinivas Bharath M M; Richard H Row; James Murray; Michael P Cusack; Roderick A Capaldi; Curt R Freed; Kedar N Prasad; Julie K Andersen; Bradford W Gibson
Journal:  Mol Cell Proteomics       Date:  2004-12-10       Impact factor: 5.911

7.  Isotope-coded affinity tag (ICAT) approach to redox proteomics: identification and quantitation of oxidant-sensitive cysteine thiols in complex protein mixtures.

Authors:  Mahadevan Sethuraman; Mark E McComb; Hua Huang; Sequin Huang; Tyler Heibeck; Catherine E Costello; Richard A Cohen
Journal:  J Proteome Res       Date:  2004 Nov-Dec       Impact factor: 4.466

8.  Mitochondrial complex I activity is impaired during HIV-1-induced T-cell apoptosis.

Authors:  J S Ladha; M K Tripathy; D Mitra
Journal:  Cell Death Differ       Date:  2005-11       Impact factor: 15.828

9.  Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant glutathione, on the murine nigrostriatal neurons.

Authors:  J K Andersen; J Q Mo; D G Hom; F Y Lee; P Harnish; R W Hamill; T H McNeill
Journal:  J Neurochem       Date:  1996-11       Impact factor: 5.372

10.  Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.

Authors:  R E Heikkila; W J Nicklas; I Vyas; R C Duvoisin
Journal:  Neurosci Lett       Date:  1985-12-18       Impact factor: 3.046

View more
  29 in total

Review 1.  Glutathione and modulation of cell apoptosis.

Authors:  Magdalena L Circu; Tak Yee Aw
Journal:  Biochim Biophys Acta       Date:  2012-06-23

Review 2.  Redox Systems Biology: Harnessing the Sentinels of the Cysteine Redoxome.

Authors:  Jason M Held
Journal:  Antioxid Redox Signal       Date:  2019-09-09       Impact factor: 8.401

3.  Antioxidant treatment normalizes mitochondrial energetics and myocardial insulin sensitivity independently of changes in systemic metabolic homeostasis in a mouse model of the metabolic syndrome.

Authors:  Olesya Ilkun; Nicole Wilde; Joseph Tuinei; Karla M P Pires; Yi Zhu; Heiko Bugger; Jamie Soto; Benjamin Wayment; Curtis Olsen; Sheldon E Litwin; E Dale Abel
Journal:  J Mol Cell Cardiol       Date:  2015-05-22       Impact factor: 5.000

Review 4.  Thiol-redox signaling, dopaminergic cell death, and Parkinson's disease.

Authors:  Aracely Garcia-Garcia; Laura Zavala-Flores; Humberto Rodriguez-Rocha; Rodrigo Franco
Journal:  Antioxid Redox Signal       Date:  2012-05-03       Impact factor: 8.401

Review 5.  Recent advances in quantitative neuroproteomics.

Authors:  George E Craft; Anshu Chen; Angus C Nairn
Journal:  Methods       Date:  2013-04-25       Impact factor: 3.608

Review 6.  OXPHOS mutations and neurodegeneration.

Authors:  Werner J H Koopman; Felix Distelmaier; Jan A M Smeitink; Peter H G M Willems
Journal:  EMBO J       Date:  2012-11-13       Impact factor: 11.598

Review 7.  Regulatory control or oxidative damage? Proteomic approaches to interrogate the role of cysteine oxidation status in biological processes.

Authors:  Jason M Held; Bradford W Gibson
Journal:  Mol Cell Proteomics       Date:  2011-12-08       Impact factor: 5.911

Review 8.  Selective vulnerability of synaptic signaling and metabolism to nitrosative stress.

Authors:  Alexander A Mongin; Preeti Dohare; David Jourd'heuil
Journal:  Antioxid Redox Signal       Date:  2012-04-18       Impact factor: 8.401

Review 9.  Proteomic approaches to quantify cysteine reversible modifications in aging and neurodegenerative diseases.

Authors:  Liqing Gu; Renã A S Robinson
Journal:  Proteomics Clin Appl       Date:  2016-11-11       Impact factor: 3.494

10.  Zonisamide attenuates MPP+-induced oxidative toxicity through modulation of Ca2+ signaling and caspase-3 activity in neuronal PC12 cells.

Authors:  Vedat Ali Yürekli; Semih Gürler; Mustafa Nazıroğlu; Abdülhadi Cihangir Uğuz; Hasan Rifat Koyuncuoğlu
Journal:  Cell Mol Neurobiol       Date:  2012-11-15       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.